Companies / Ngm Biopharmaceuticals Inc
Ngm Biopharmaceuticals Inc
NGMCIK 1426332
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 9, 2022 | Goeddel David V +2 co-filers Director | Buy Open-market buy | Common Stock | $12.85M | +952K +56.03% | 2,650,177 | high |
| Jun 1, 2022 | Goeddel David V +2 co-filers Director | Buy Open-market buy | Common Stock | $1.20M | +89K +5.64% | 1,665,422 | high |
| May 17, 2022 | Goeddel David V +2 co-filers Director | Buy Open-market buy | Common Stock | $1.16M | +86K +6.89% | 1,336,461 | high |
| Jan 11, 2023 | Goeddel David V +3 co-filers Director | Buy Open-market buy | Common Stock | $994.8K | +209K +43.49% | 689,542 | high |
| May 12, 2022 | Goeddel David V +2 co-filers Director | Buy Open-market buy | Common Stock | $929.0K | +80K +7.89% | 1,092,698 | high |
| Jan 31, 2023 | Goeddel David V +3 co-filers Director | Buy Open-market buy | Common Stock | $883.4K | +177K +23.55% | 927,231 | high |
| May 11, 2022 | Goeddel David V +2 co-filers Director | Buy Open-market buy | Common Stock | $874.1K | +78K +8.35% | 1,010,189 | high |
| May 9, 2022 | Goeddel David V +2 co-filers Director | Buy Open-market buy | Common Stock | $868.1K | +80K +9.79% | 902,090 | high |